204 related articles for article (PubMed ID: 17895560)
1. Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone.
Yamada Y; Shiga T; Matsuda N; Hagiwara N; Kasanuki H
Circ J; 2007 Oct; 71(10):1610-6. PubMed ID: 17895560
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of amiodarone-induced pulmonary toxicity.
Dusman RE; Stanton MS; Miles WM; Klein LS; Zipes DP; Fineberg NS; Heger JJ
Circulation; 1990 Jul; 82(1):51-9. PubMed ID: 2364524
[TBL] [Abstract][Full Text] [Related]
3. Serum mucin antigen (CASA) as a marker of amiodarone-induced pulmonary toxicity.
Devine PL; Siebert WJ; Morton SL; Scells B; Quin RJ; Heddle WF; Zimmerman PV; Donohoe PJ
Dis Markers; 1998 Nov; 14(3):169-75. PubMed ID: 10427477
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity.
Kang IS; Kim KJ; Kim Y; Park SH
Korean J Intern Med; 2014 Nov; 29(6):746-53. PubMed ID: 25378973
[TBL] [Abstract][Full Text] [Related]
5. [Early diagnosis of amiodarone-induced pulmonary toxicity: are repeated lung function tests of any value?].
Ulrik CS; Aldershvile J
Ugeskr Laeger; 1996 Jun; 158(24):3445-7. PubMed ID: 8650812
[TBL] [Abstract][Full Text] [Related]
6. Initial characteristics and outcome of hospitalized patients with amiodarone pulmonary toxicity.
Mankikian J; Favelle O; Guillon A; Guilleminault L; Cormier B; Jonville-Béra AP; Perrotin D; Diot P; Marchand-Adam S
Respir Med; 2014 Apr; 108(4):638-46. PubMed ID: 24565600
[TBL] [Abstract][Full Text] [Related]
7. Serum KL-6 as a possible marker for amiodarone-induced pulmonary toxicity.
Nakajima M; Kawahara Y; Yoshida K; Miyashita N; Niki Y; Matsushima T
Intern Med; 2000 Dec; 39(12):1097-100. PubMed ID: 11197799
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone pulmonary toxicity: prospective evaluation of serial pulmonary function tests.
Magro SA; Lawrence EC; Wheeler SH; Krafchek J; Lin HT; Wyndham CR
J Am Coll Cardiol; 1988 Sep; 12(3):781-8. PubMed ID: 3403839
[TBL] [Abstract][Full Text] [Related]
9. Serial pulmonary function tests in patients treated with low-dose amiodarone.
Ulrik CS; Backer V; Aldershvile J; Pietersen AH
Am Heart J; 1992 Jun; 123(6):1550-4. PubMed ID: 1595534
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of and effects of angiotensin system antagonists on amiodarone-induced pulmonary toxicity.
Nikaido A; Tada T; Nakamura K; Murakami M; Banba K; Nishii N; Fuke S; Nagase S; Sakuragi S; Morita H; Ohe T; Kusano KF
Int J Cardiol; 2010 Apr; 140(3):328-35. PubMed ID: 19106010
[TBL] [Abstract][Full Text] [Related]
11. Amiodarone-induced acute lung toxicity in an ICU setting.
Skroubis G; Galiatsou E; Metafratzi Z; Karahaliou A; Kitsakos A; Nakos G
Acta Anaesthesiol Scand; 2005 Apr; 49(4):569-71. PubMed ID: 15777308
[TBL] [Abstract][Full Text] [Related]
12. Reduction of amiodarone pulmonary toxicity in patients treated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kosseifi SG; Halawa A; Bailey B; Micklewright M; Roy TM; Byrd RP
Ther Adv Respir Dis; 2009 Dec; 3(6):289-94. PubMed ID: 19850648
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a pharmacist-managed amiodarone monitoring program.
Spence MM; Polzin JK; Weisberger CL; Martin JP; Rho JP; Willick GH
J Manag Care Pharm; 2011 Sep; 17(7):513-22. PubMed ID: 21870892
[TBL] [Abstract][Full Text] [Related]
14. Amiodaronoma: an unusual form of amiodarone-induced pulmonary toxicity.
Jarand J; Lee A; Leigh R
CMAJ; 2007 May; 176(10):1411-3. PubMed ID: 17485692
[No Abstract] [Full Text] [Related]
15. Amiodarone pulmonary toxicity: early changes in pulmonary function tests during amiodarone rechallenge.
Veltri EP; Reid PR
J Am Coll Cardiol; 1985 Oct; 6(4):802-5. PubMed ID: 4031295
[TBL] [Abstract][Full Text] [Related]
16. [Amiodarone-induced pulmonary toxicity].
Heisel A; Berg M; Stopp M; Ukena D; Schieffer H
Med Klin (Munich); 1997 Dec; 92 Suppl 5():33-6. PubMed ID: 19479394
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of KL-6 as a marker of amiodarone-induced pulmonary toxicity.
Endoh Y; Hanai R; Uto K; Tanaka T; Ohta Y; Kasanuki H; Ohnishi S
Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):2010-3. PubMed ID: 11139980
[TBL] [Abstract][Full Text] [Related]
18. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I).
Martin WJ; Rosenow EC
Chest; 1988 May; 93(5):1067-75. PubMed ID: 3282816
[TBL] [Abstract][Full Text] [Related]
19. Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations.
Pollak PT
Am J Cardiol; 1999 Nov; 84(9A):37R-45R. PubMed ID: 10568658
[TBL] [Abstract][Full Text] [Related]
20. Amiodarone pulmonary toxicity.
Camus P; Martin WJ; Rosenow EC
Clin Chest Med; 2004 Mar; 25(1):65-75. PubMed ID: 15062598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
